Poseida Therapeutics Statistics
Total Valuation
PSTX has a market cap or net worth of $310.26 million. The enterprise value is $196.18 million.
| Market Cap | 310.26M |
| Enterprise Value | 196.18M |
Important Dates
The last earnings date was Tuesday, May 14, 2024, after market close.
| Earnings Date | May 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PSTX has 96.96 million shares outstanding. The number of shares has increased by 11.31% in one year.
| Shares Outstanding | 96.96M |
| Shares Change (YoY) | +11.31% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 27.67% |
| Owned by Institutions (%) | 55.25% |
| Float | 64.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.76 |
| Forward PS | 6.52 |
| PB Ratio | 3.67 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.56, with a Debt / Equity ratio of 1.00.
| Current Ratio | 2.56 |
| Quick Ratio | 2.49 |
| Debt / Equity | 1.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.22 |
Financial Efficiency
Return on equity (ROE) is -97.40% and return on invested capital (ROIC) is -67.73%.
| Return on Equity (ROE) | -97.40% |
| Return on Assets (ROA) | -38.90% |
| Return on Capital (ROIC) | -67.73% |
| Revenue Per Employee | $250,006 |
| Profits Per Employee | -$329,870 |
| Employee Count | 330 |
| Asset Turnover | 0.30 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PSTX has paid $107,000 in taxes.
| Income Tax | 107,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.15% in the last 52 weeks. The beta is 0.46, so PSTX's price volatility has been lower than the market average.
| Beta (1Y) | 0.46 |
| 52-Week Price Change | +18.15% |
| 50-Day Moving Average | 2.82 |
| 200-Day Moving Average | 2.75 |
| Relative Strength Index (RSI) | 60.21 |
| Average Volume (30 Days) | 709,688 |
Short Selling Information
The latest short interest is 6.04 million, so 6.23% of the outstanding shares have been sold short.
| Short Interest | 6.04M |
| Short Previous Month | 4.05M |
| Short % of Shares Out | 6.23% |
| Short % of Float | 9.40% |
| Short Ratio (days to cover) | 11.48 |
Income Statement
In the last 12 months, PSTX had revenue of $82.50 million and -$108.86 million in losses. Loss per share was -$1.18.
| Revenue | 82.50M |
| Gross Profit | 82.50M |
| Operating Income | -114.56M |
| Pretax Income | -108.75M |
| Net Income | -108.86M |
| EBITDA | -94.18M |
| EBIT | -99.85M |
| Loss Per Share | -$1.18 |
Balance Sheet
The company has $198.65 million in cash and $84.56 million in debt, giving a net cash position of $114.09 million or $1.18 per share.
| Cash & Cash Equivalents | 198.65M |
| Total Debt | 84.56M |
| Net Cash | 114.09M |
| Net Cash Per Share | $1.18 |
| Equity / Book Value | 84.59M |
| Book Value Per Share | 0.87 |
| Working Capital | 131.97M |
Cash Flow
In the last 12 months, operating cash flow was -$69.30 million and capital expenditures -$2.41 million, giving a free cash flow of -$71.71 million.
| Operating Cash Flow | -69.30M |
| Capital Expenditures | -2.41M |
| Free Cash Flow | -71.71M |
| FCF Per Share | -$0.75 |
Margins
Gross margin is 100.00%, with operating and profit margins of -138.86% and -131.94%.
| Gross Margin | 100.00% |
| Operating Margin | -138.86% |
| Pretax Margin | -131.81% |
| Profit Margin | -131.94% |
| EBITDA Margin | -114.16% |
| EBIT Margin | -121.03% |
| FCF Margin | -86.92% |
Dividends & Yields
PSTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.31% |
| Shareholder Yield | -11.31% |
| Earnings Yield | -35.09% |
| FCF Yield | -23.11% |
Analyst Forecast
The average price target for PSTX is $14.67, which is 359.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.67 |
| Price Target Difference | 359.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 29.65% |
| EPS Growth Forecast (5Y) | -35.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PSTX has an Altman Z-Score of -2.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.59 |
| Piotroski F-Score | 2 |